+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immune Pharmaceuticals - logo

Immune Pharmaceuticals is a clinical stage biopharmaceutical company that develops novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas. The company's lead product candidate is Bertilimumab, a human monoclonal antibody, which is in Phase II clinical trial for the treatment of ulcerative colitis, bullous pemphigoid, and Crohn's disease. Immune Pharmaceuticals, Inc. was founded in 2010 and is headquartered in New York, New York.

Psoriasis (Immunology) - Drugs In Development, 2021 - Product Thumbnail Image

Psoriasis (Immunology) - Drugs In Development, 2021

  • Report
  • July 2021
  • 1178 Pages
From
Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2020 - Product Thumbnail Image

Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 684 Pages
From
From
From
From
From
Atopic Dermatitis - Pipeline Review, H2 2019 - Product Thumbnail Image

Atopic Dermatitis - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 597 Pages
From
From
Psoriasis - Pipeline Review, H2 2020 - Product Thumbnail Image

Psoriasis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 956 Pages
From
From
From
From
From
From
Diabetic Neuropathic Pain - Pipeline Insight, 2020 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
From
From
Ovarian Cancer (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

Ovarian Cancer (Oncology) - Drugs in Development, 2021

  • Report
  • December 2021
  • 5066 Pages
From
Loading Indicator